Employers
Loading campaign finance records…
Loading campaign finance records…
2023–2024 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Latest matching employer records · memo entries excluded from net amount
Read from indexed records .
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under ALKEUS PHARMACEUTICALS.
These totals and connections use all matching indexed employer records, keeping the latest version within that employer group and excluding memo entries from net amounts. Amendments that change the reported employer may affect this grouping. No profile rebuild is required.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for ALKEUS PHARMACEUTICALS. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported name and ZIP groups; not verified unique people or cross-address identity matches · 10 per page
Showing 1–2 of 2 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · BOSTON · MA · 02210 · ALKEUS PHARMACEUTICALS, INC. · EXECUTIVE
97% Democratic · 0% unclassifiedDerived from contributionsReported name + ZIP cluster; not a verified identity merge · BOSTON · MA · 02210 · ALKEUS PHARMACEUTICALS · BIOTECH EXECUTIVE
DemocraticDerived from contributionsWhere the contributions went · 10 per page
Showing 1–10 of 20 · largest absolute amount first
PAC (not qualified) · WASHINGTON · DC
100% Democratic · 0% unclassifiedDerived from contributionsHouse campaign committee · MANCHESTER · NH · PAPPAS, CHRIS · U.S. House · NH · 01
DemocraticDerived from contributionsHouse campaign committee · DORCHESTER CENTER · MA · PRESSLEY, AYANNA · U.S. House · MA · 07
DemocraticDerived from contributionsPAC (not qualified) · WASHINGTON · DC
98% Democratic · 2% unclassifiedDerived from contributionsHouse campaign committee · SALEM · MA · MOULTON, SETH · U.S. House · MA · 06
DemocraticDerived from contributionsParty committee (qualified) · BOSTON · MA
DemocraticDerived from contributionsPAC (not qualified) · WASHINGTON · DC
100% DemocraticDerived from contributionsIndividual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↓ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2024-05-06FEC filing ↗ | $50,000 | BOGER, JOSHUABOSTONMA02210EXECUTIVEALKEUS PHARMACEUTICALS, INC. | HARRIS VICTORY FUNDC00744946Primary (P)Filing 1802357 |
| 2024-10-16FEC filing ↗ | $25,000 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR AB PAC UNLIMITED (C00492140)Filing 1841874 |
| 2024-10-16FEC filing ↗ | $25,000 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | AB PACC00492140Primary (P)NON-CONTRIBUTION ACCOUNTFiling 1878191 · amended |
| 2024-09-08FEC filing ↗ | $25,000 | BOGER, JOSHUABOSTONMA02210EXECUTIVE CHAIRMANALKEUS PHARMACEUTICALS | KATHERINE CLARK VICTORY FUNDC00831917Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE ON 09/08/2024Filing 1825583 |
| 2024-05-26FEC filing ↗ | $16,600 | BOGER, JOSHUA SBOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | MASSACHUSETTS VICTORY 2024C00879411Primary (P)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1797058 |
| 2024-05-26FEC filing ↗ | $16,600 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR MASSACHUSETTS VICTORY 2024 (C00879411)Filing 1791562 |
| 2024-03-30FEC filing ↗ | $6,600 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | KATHERINE CLARK MAJORITY FUNDC00831669Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE ON 03/31/2024Filing 1773544 |
| 2024-03-30FEC filing ↗ | $6,600 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR KATHERINE CLARK MAJORITY FUND (C00831669)Filing 1779040 |
| 2024-07-28FEC filing ↗ | $6,600 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR CHRIS PAPPAS FOR CONGRESS (C00660464)Filing 1864088 · amended |
| 2024-04-18FEC filing ↗ | $6,600 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR THE COMMITTEE TO ELECT AYANNA PRESSLEY (C00667741)Filing 1785179 |
Refunds remain negative. Memo-only rows are marked and are not additional money. Latest versions are selected within matching employer records; amendments that change the employer may affect the grouping.
Open full contribution table →Reported as ALKEUS PHARMACEUTICALS
Industry classification summary
Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for retinal diseases, as documented in its official about page and clinical news releases.
AI-generated classification based on saved sources
View source